The Medical Advisor

Despite  trillions spent on cancer research  ( The Lancet Oncology ), cancer still  kills around 10 million people a year  ( WHO ) and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide. The 2026 American Association of Cancer Research (AACR) Annual Meeting took place in San Diego from April 17-22 and reflected how cancer research continues to evolve. Progress is increasingly driven by how advances across biology, technology, and policy come together to shape how we understand disease, develop new treatments, and bring them into practice. A central theme this year was the continued focus on cancer as more than just a collection of tumor cells. It is shaped by a complex ecosystem — immune cells, surrounding tissue, metabolism, and even the microbiome — all interacting in dynamic ways. Credit:  ...

CAR T-cell therapy (Chimeric Antigen Receptor T-Cell) is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.” This article provides a comprehensive list of CAR-T therapy companies worldwide. Read on to learn more about innovative CAR-T cell therapy companies and the technologies they are using to fight cancer. CAR-T Cell Therapy Industry In 1987, Israeli immunologist Dr. Zelig Eshhar from the Weizmann Institute of Science developed the first “chimeric antigen receptor” (CAR), laying the foundation for modern CAR-T cell therapy. CARs are synthetic, engineered receptor proteins designed in the laboratory and do not exist naturally in the human body. Chimeric antigen receptor (CAR) T-cell therapy involves genetically modifying a patient’s own T cells to express these engineered receptors, e...